1. Home
  2. PHAR vs AMRC Comparison

PHAR vs AMRC Comparison

Compare PHAR & AMRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAR
  • AMRC
  • Stock Information
  • Founded
  • PHAR 1988
  • AMRC 2000
  • Country
  • PHAR Netherlands
  • AMRC United States
  • Employees
  • PHAR N/A
  • AMRC N/A
  • Industry
  • PHAR Biotechnology: Pharmaceutical Preparations
  • AMRC Engineering & Construction
  • Sector
  • PHAR Health Care
  • AMRC Consumer Discretionary
  • Exchange
  • PHAR Nasdaq
  • AMRC Nasdaq
  • Market Cap
  • PHAR 587.5M
  • AMRC 701.9M
  • IPO Year
  • PHAR N/A
  • AMRC 2010
  • Fundamental
  • Price
  • PHAR N/A
  • AMRC $9.95
  • Analyst Decision
  • PHAR Strong Buy
  • AMRC Buy
  • Analyst Count
  • PHAR 3
  • AMRC 8
  • Target Price
  • PHAR $30.00
  • AMRC $24.86
  • AVG Volume (30 Days)
  • PHAR 4.6K
  • AMRC 749.1K
  • Earning Date
  • PHAR 05-08-2025
  • AMRC 05-05-2025
  • Dividend Yield
  • PHAR N/A
  • AMRC N/A
  • EPS Growth
  • PHAR N/A
  • AMRC N/A
  • EPS
  • PHAR N/A
  • AMRC 1.07
  • Revenue
  • PHAR $297,200,000.00
  • AMRC $1,769,928,000.00
  • Revenue This Year
  • PHAR $8.26
  • AMRC $8.14
  • Revenue Next Year
  • PHAR $9.73
  • AMRC $11.08
  • P/E Ratio
  • PHAR N/A
  • AMRC $9.30
  • Revenue Growth
  • PHAR 21.15
  • AMRC 28.76
  • 52 Week Low
  • PHAR $6.65
  • AMRC $9.00
  • 52 Week High
  • PHAR $11.07
  • AMRC $39.68
  • Technical
  • Relative Strength Index (RSI)
  • PHAR 45.53
  • AMRC 38.46
  • Support Level
  • PHAR $7.79
  • AMRC $9.50
  • Resistance Level
  • PHAR $8.51
  • AMRC $10.62
  • Average True Range (ATR)
  • PHAR 0.47
  • AMRC 0.93
  • MACD
  • PHAR 0.01
  • AMRC 0.07
  • Stochastic Oscillator
  • PHAR 49.08
  • AMRC 27.86

About PHAR Pharming Group N.V.

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.

About AMRC Ameresco Inc.

Ameresco Inc provides energy efficiency solutions for facilities in North America and Europe. It focuses on projects that reduce energy, also focuses on the operations and maintenance costs of governmental, educational, utility, healthcare, and other institutional, commercial, and industrial entities facilities. Ameresco distributes solar energy products and systems, such as PV panels, solar regulators, solar charge controllers, inverters, solar-powered lighting systems, solar-powered water pumps, solar panel mounting hardware, and other system components. The company's segment includes U.S. Regions; U.S. Federal; Canada; Alternative Fuels; Non-Solar DG and All Other. It derives a majority of revenue from the U.S. Regions segment.

Share on Social Networks: